Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer-Schering Pharma

This article was originally published in The Tan Sheet

Executive Summary

Bayer is closer to completing its friendly takeover of Schering AG after Merck KgaA agreed to relinquish its 21.8% share June 14. As of June 13, Bayer reported ownership of 23.36% of Schering shares; a 75% stake is required. Despite dropping its bid in March, Merck had bought Schering stock to bulk up its share. In response, Bayer filed suit in Manhattan federal court June 13, but dropped the charge the next day...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel